| Name | ALK and LTK ligand 1 |
| Description | Enables protein tyrosine kinase activator activity and signaling receptor binding activity. Involved in cell surface receptor protein tyrosine kinase signaling pathway; positive regulation of MAPK cascade; and positive regulation of neuron projection development. Is active in extracellular space. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\n ALKAL1 (also referred to as FAM150A or augmentor‐β) is a secreted ligand that plays a critical role in the activation of the anaplastic lymphoma kinase (ALK) receptor tyrosine kinase. Studies have demonstrated that ALKAL1 binds directly to the extracellular domain of ALK, triggering receptor dimerization and subsequent autophosphorylation that stimulates downstream signaling cascades—including MAP kinase pathways—that are essential for cell proliferation, differentiation, and, in cancer contexts, oncogenic transformation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": " In addition, biochemical analyses reveal that although ALKAL1 and its related ligand ALKAL2 (also known as FAM150B or augmentor‐α) both interact with ALK and the closely related receptor LTK, subtle differences in their binding properties and specificities appear to influence how they modulate receptor activation and downstream signaling in various tissues."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": " Moreover, detailed studies on ligand production and stability indicate that engineered forms of ALKAL1 retain their capacity to stimulate ALK phosphorylation and evoke a similar profile of MAP kinase responses, substantiating its functional activity even when portions of its N-terminal region are removed."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "5"}]}, {"type": "t", "text": " In vivo investigations, particularly in zebrafish models, have further confirmed the physiological relevance of ALKAL1 in modulating ALK‐driven developmental processes and oncogenic signaling pathways."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "6"}]}, {"type": "t", "text": " Finally, emerging clinical studies have begun to correlate elevated ALKAL1 expression with tumor progression in cancers such as colorectal carcinoma, suggesting that ALKAL1 might serve not only as a key activator of ALK signaling but also as a potential prognostic biomarker and therapeutic target in oncology."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "7"}]}, {"type": "t", "text": "\n "}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Jikui Guan, Ganesh Umapathy, Yasuo Yamazaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "FAM150A and FAM150B are activating ligands for anaplastic lymphoma kinase."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Elife (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7554/eLife.09811"}], "href": "https://doi.org/10.7554/eLife.09811"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26418745"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26418745"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Andrey V Reshetnyak, Phillip B Murray, Xiarong Shi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Augmentor α and β (FAM150) are ligands of the receptor tyrosine kinases ALK and LTK: Hierarchy and specificity of ligand-receptor interactions."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1520099112"}], "href": "https://doi.org/10.1073/pnas.1520099112"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26630010"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26630010"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Andrey Fadeev, Patricia Mendoza-Garcia, Uwe Irion, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ALKALs are in vivo ligands for ALK family receptor tyrosine kinases in the neural crest and derived cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1719137115"}], "href": "https://doi.org/10.1073/pnas.1719137115"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29317532"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29317532"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Hongbing Zhang, Lily I Pao, Aileen Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Deorphanization of the human leukocyte tyrosine kinase (LTK) receptor by a signaling screen of the extracellular proteome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1412009111"}], "href": "https://doi.org/10.1073/pnas.1412009111"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25331893"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25331893"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Andrey V Reshetnyak, Jyotidarsini Mohanty, Francisco Tomé, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a biologically active fragment of ALK and LTK-Ligand 2 (augmentor-α)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1807881115"}], "href": "https://doi.org/10.1073/pnas.1807881115"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30061385"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30061385"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Elizabeth S Mo, Qianni Cheng, Andrey V Reshetnyak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Alk and Ltk ligands are essential for iridophore development in zebrafish mediated by the receptor tyrosine kinase Ltk."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1710254114"}], "href": "https://doi.org/10.1073/pnas.1710254114"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29078341"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29078341"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Shasha Chen, Bin Wang, Xuekun Fu, et al. "}, {"type": "b", "children": [{"type": "a", "children": [{"type": "t", "text": "i"}], "href": "i"}, {"type": "t", "text": "ALKAL1"}, {"type": "a", "children": [{"type": "t", "text": "/i"}], "href": "/i"}, {"type": "t", "text": " gene silencing prevents colorectal cancer progression via suppressing Sonic Hedgehog (SHH) signaling pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cancer (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.7150/jca.46447"}], "href": "https://doi.org/10.7150/jca.46447"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33391411"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33391411"}]}]}]}
|
| NCBI Gene ID | 389658 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
ALKAL1 has 954 functional associations with biological entities spanning 5 categories (functional term, phrase or reference, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 19 datasets.
Click the + buttons to view associations for ALKAL1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ALKAL1 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of ALKAL1 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with ALKAL1 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with ALKAL1 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| GlyGen Glycosylated Proteins | ligands (chemical) binding ALKAL1 protein from the GlyGen Glycosylated Proteins dataset. | |
| GO Biological Process Annotations 2025 | biological processes involving ALKAL1 gene from the curated GO Biological Process Annotations2025 dataset. | |
| GO Molecular Function Annotations 2025 | molecular functions performed by ALKAL1 gene from the curated GO Molecular Function Annotations 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of ALKAL1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with ALKAL1 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| HuBMAP Azimuth Cell Type Annotations | cell types associated with ALKAL1 gene from the HuBMAP Azimuth Cell Type Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of ALKAL1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of ALKAL1 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| PFOCR Pathway Figure Associations 2024 | pathways involving ALKAL1 protein from the Wikipathways PFOCR 2024 dataset. | |
| Reactome Pathways 2024 | pathways involving ALKAL1 protein from the Reactome Pathways 2024 dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of ALKAL1 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of ALKAL1 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of ALKAL1 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of ALKAL1 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with ALKAL1 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |